Ingelise Jensen
About
Ingelise Jensen is a scholar working on Cancer Research, Oncology and Radiation.
According to data from OpenAlex, Ingelise Jensen has authored 22 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 8 papers in Oncology and 6 papers in Radiation. Recurrent topics in Ingelise Jensen's work include Breast Cancer Treatment Studies (14 papers), Advanced Radiotherapy Techniques (6 papers) and Cancer Risks and Factors (5 papers). Ingelise Jensen is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Advanced Radiotherapy Techniques (6 papers) and Cancer Risks and Factors (5 papers). Ingelise Jensen collaborates with scholars based in Denmark, Norway and Netherlands. Ingelise Jensen's co-authors include Birgitte Vrou Offersen, Martin Berg, Anders N. Pedersen, Jens Overgaard, S.J. Zimmermann, Lise Bech Jellesmark Thorsen, Marie Overgaard, Mette S. Thomsen, Hella Danø and Ebbe Laugaard Lorenzen and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Diabetologia.
In The Last Decade
Ingelise Jensen
21 papers receiving 889 citations
Peers
Ingelise Jensen
Lone Gothard United Kingdom
Carine Kirkove Belgium
Lars Stenbygaard Denmark
Ebbe Laugaard Lorenzen Denmark
Dan Lundstedt Sweden
Gunilla Svane Sweden
Akke Botma Netherlands
Kazuhiko Sato Japan
M. Giulia Cicchetti United States
Lise Bech Jellesmark Thorsen Denmark
Citations per year, relative to Ingelise Jensen Ingelise Jensen (= 1×)
peers
Lone Gothard
Countries citing papers authored by Ingelise Jensen
Since
Specialization
Citations
This map shows the geographic impact of Ingelise Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingelise Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingelise Jensen more than expected).
Fields of papers citing papers by Ingelise Jensen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ingelise Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingelise Jensen. The network helps show where Ingelise Jensen may publish in the future.
Co-authorship network of co-authors of Ingelise Jensen
This figure shows the co-authorship network connecting the top 25 collaborators of Ingelise Jensen. A scholar is included among the top collaborators of Ingelise Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingelise Jensen. Ingelise Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Thomsen, Mette S., Jan Alsner, Christina Maria Lutz, et al.. (2024). Breast induration and irradiated volume in the DBCG HYPO trial: The impact of age, smoking, and boost. Radiotherapy and Oncology. 201. 110574–110574.
2.
Jensen, Jesper Møller, Ingelise Jensen, Mette Holck Nielsen, et al.. (2024). The effect of coronary artery calcifications and radiotherapy on the risk of coronary artery disease in high-risk breast cancer patients in the DBCG RT-Nation cohort. Radiotherapy and Oncology. 204. 110705–110705.
3.
Thomsen, Mette S., Karen Andersen, Ingelise Jensen, et al.. (2024). 761: Quality assurance of internal mammary node irradiation 2007-14: The DBCG IMN2 study. Radiotherapy and Oncology. 194. S511–S514.
4.
Nielsen, Mette Holck, Lars Stenbygaard, Anders N. Pedersen, et al.. (2024). Benefit of respiratory gating in the Danish Breast Cancer Group partial breast irradiation trial. Radiotherapy and Oncology. 194. 110195–110195.
5.
Møller, Ditte Sloth, Lone Hoffmann, Henrik Dahl Nissen, et al.. (2023). Radiation dose to heart and cardiac substructures and risk of coronary artery disease in early breast cancer patients: A DBCG study based on modern radiation therapy techniques. Radiotherapy and Oncology. 180. 109453–109453.
6.
Thomsen, Mette S., Jan Alsner, Hanne Melgaard Nielsen, et al.. (2022). Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial. Radiotherapy and Oncology. 177. 231–235.
7.
Offersen, Birgitte Vrou, Jan Alsner, Hanne Melgaard Nielsen, et al.. (2022). Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial. Journal of Clinical Oncology. 40(36). 4189–4197.
8.
Lorenzen, Ebbe Laugaard, Esben Svitzer Yates, Carmel Anandadas, et al.. (2021). Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy. Clinical and Translational Radiation Oncology. 27. 126–131.
9.
Lorenzen, Ebbe Laugaard, Jason Dowling, Ingelise Jensen, et al.. (2020). Analysis of cardiac substructure dose in a large, multi-centre danish breast cancer cohort (the DBCG HYPO trial): Trends and predictive modelling. Radiotherapy and Oncology. 153. 130–138.
10.
Francolini, Giulio, Mette S. Thomsen, Esben Svitzer Yates, et al.. (2017). Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1. Radiotherapy and Oncology. 123(2). 282–287.
11.
Brink, Carsten, Ebbe Laugaard Lorenzen, Jonas Westberg, et al.. (2017). DBCG hypo trial validation of radiotherapy parameters from a national data bank versus manual reporting. Acta Oncologica. 57(1). 107–112.
12.
Berg, Martin, Ebbe Laugaard Lorenzen, Ingelise Jensen, et al.. (2017). The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial. Acta Oncologica. 57(1). 113–119.
13.
Yates, Esben Svitzer, Mette S. Thomsen, Hanne Melgaard Nielsen, et al.. (2016). Internal and external validation of an ESTRO delineation guideline – dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer. Radiotherapy and Oncology. 121(3). 424–430.
14.
Thorsen, Lise Bech Jellesmark, Birgitte Vrou Offersen, Hella Danø, et al.. (2015). DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. Journal of Clinical Oncology. 34(4). 314–320.
15.
Thorsen, Lise Bech Jellesmark, Mette S. Thomsen, Martin Berg, et al.. (2014). CT-planned internal mammary node radiotherapy in the DBCG-IMN study: Benefit versus potentially harmful effects. Acta Oncologica. 53(8). 1027–1034.
16.
Nielsen, Mette Holck, Martin Berg, Anders N. Pedersen, et al.. (2013). Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncologica. 52(4). 703–710.
17.
Jensen, Ingelise, et al.. (2010). Radiobiological Impact of Reduced Margins and Treatment Technique for Prostate Cancer in Terms of Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP). Medical dosimetry. 36(2). 130–137.
18.
Jensen, Ingelise, Jens Faber, & Niels Grunnet. (1990). Familial Occurrence of Dysalbuminaemic Hyperthyroxinaemia, Lipomatosis and Ankylosing Spondylitis. Scandinavian Journal of Rheumatology. 19(4). 303–305.
19.
Mourits‐Andersen, Torben, Ingelise Jensen, Lene Kongsgaard Nielsen, et al.. (1990). Plasma 6-keto-PGF1α, thromboxane B2 and PGE2 during diabetic ketoacidosis. Prostaglandins Leukotrienes and Essential Fatty Acids. 40(1). 39–43.
20.
Mourits‐Andersen, Torben, et al.. (1987). Plasma 6-keto-PGF1?, thromboxane B2 and PGE2 in Type 1 (insulin-dependent) diabetic patients during exercise. Diabetologia. 30(7). 460–463.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lone Gothard Breakdown of academic impact, for papers by Carine Kirkove Breakdown of academic impact, for papers by Lars Stenbygaard Breakdown of academic impact, for papers by Ebbe Laugaard Lorenzen Breakdown of academic impact, for papers by Dan Lundstedt Breakdown of academic impact, for papers by Gunilla Svane Breakdown of academic impact, for papers by Akke Botma Breakdown of academic impact, for papers by Kazuhiko Sato Breakdown of academic impact, for papers by M. Giulia Cicchetti Breakdown of academic impact, for papers by Lise Bech Jellesmark Thorsen